Akebia Therapeutics, Inc. - AKBA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 03, 2026 | — | A | A | 214,400.0 | 0.0 | 0.0 | 214,400.0 | View | |
| Mar 05, 2026 | CEO and President | P | A | 69,270.0 | 1.25 | 86,587.5 | 3,367,064.0 | View | |
| Feb 04, 2026 | SVP, Chief Legal Officer | S | D | 27,544.0 | 1.39 | 38,286.16 | 588,378.0 | View | |
| Feb 04, 2026 | SVP, Chief Legal Officer | S | D | 25,382.0 | 1.39 | 35,280.98 | 615,922.0 | View | |
| Feb 04, 2026 | SVP, Chief Legal Officer | S | D | 16,846.0 | 1.39 | 23,415.94 | 641,304.0 | View | |
| Feb 04, 2026 | SVP, Chief Medical Officer | S | D | 20,701.0 | 1.39 | 28,774.39 | 948,432.0 | View | |
| Feb 04, 2026 | SVP, Chief Medical Officer | S | D | 25,375.0 | 1.39 | 35,271.25 | 969,133.0 | View | |
| Feb 04, 2026 | SVP, Chief Medical Officer | S | D | 21,582.0 | 1.39 | 29,998.98 | 994,508.0 | View | |
| Feb 04, 2026 | Chief Commercial Officer | S | D | 31,244.0 | 1.39 | 43,429.16 | 561,750.0 | View | |
| Feb 04, 2026 | Chief Commercial Officer | S | D | 53,585.0 | 1.39 | 74,483.15 | 592,994.0 | View | |
| Feb 04, 2026 | SVP, Chief Accounting Officer | S | D | 13,382.0 | 1.39 | 18,600.98 | 299,390.0 | View | |
| Feb 04, 2026 | SVP, Chief Accounting Officer | S | D | 36,142.0 | 1.39 | 50,237.38 | 312,772.0 | View | |
| Feb 04, 2026 | CEO and President | S | D | 83,689.0 | 1.39 | 116,327.71 | 3,297,794.0 | View | |
| Feb 04, 2026 | CEO and President | A | A | 175,250.0 | 1.41 | 247,102.5 | 3,381,483.0 | View | |
| Feb 04, 2026 | CEO and President | S | D | 114,891.0 | 1.39 | 159,698.49 | 3,206,233.0 | View | |
| Feb 04, 2026 | CEO and President | S | D | 96,065.0 | 1.39 | 133,530.35 | 3,321,124.0 | View | |
| Feb 04, 2026 | CEO and President | S | D | 46,660.0 | 1.39 | 64,857.4 | 3,417,189.0 | View | |
| Feb 04, 2026 | SVP, CFO, CBO & Treasurer | S | D | 34,951.0 | 1.39 | 48,581.89 | 672,635.0 | View | |
| Feb 03, 2026 | CEO and President | A | A | 1,115,000.0 | 0.0 | 0.0 | 1,115,000.0 | View | |
| Feb 03, 2026 | CEO and President | A | A | 743,000.0 | 0.0 | 0.0 | 3,463,849.0 | View | |
| Feb 03, 2026 | SVP, Chief Accounting Officer | A | A | 119,000.0 | 0.0 | 0.0 | 119,000.0 | View | |
| Feb 03, 2026 | SVP, Chief Accounting Officer | A | A | 79,000.0 | 0.0 | 0.0 | 348,914.0 | View | |
| Feb 03, 2026 | SVP, Chief Legal Officer | A | A | 270,000.0 | 0.0 | 0.0 | 270,000.0 | View | |
| Feb 03, 2026 | SVP, Chief Legal Officer | A | A | 190,000.0 | 0.0 | 0.0 | 658,150.0 | View | |
| Feb 03, 2026 | SVP, Chief Medical Officer | A | A | 320,000.0 | 0.0 | 0.0 | 320,000.0 | View | |
| Feb 03, 2026 | SVP, Chief Medical Officer | A | A | 204,000.0 | 0.0 | 0.0 | 1,016,090.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | A | A | 320,000.0 | 0.0 | 0.0 | 320,000.0 | View | |
| Feb 03, 2026 | Chief Commercial Officer | A | A | 204,000.0 | 0.0 | 0.0 | 646,579.0 | View | |
| Feb 03, 2026 | SVP, CFO, CBO & Treasurer | A | A | 320,000.0 | 0.0 | 0.0 | 320,000.0 | View | |
| Feb 03, 2026 | SVP, CFO, CBO & Treasurer | A | A | 204,000.0 | 0.0 | 0.0 | 707,586.0 | View |